Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Canadian Patients With Axial Spondyloarthritis Require Almost a Decade To Be Diagnosed Leading to Severe Functional Limitation. Results From the International Map of Axial Spondyloarthritis (IMAS).
Journal: Musculoskeletal care
Published: October 22, 2024
Work-Related Issues and Physical and Psychological Burden in Canadian Patients With Axial Spondyloarthritis: Results From the International Map of Axial Spondyloarthritis.
Journal: The Journal of rheumatology
Published: November 11, 2022
Use of medical cannabis by patients with fibromyalgia in Canada after cannabis legalisation: a cross-sectional study.
Journal: Clinical and experimental rheumatology
Published: March 12, 2021
Medical Cannabis Use by Rheumatology Patients Following Recreational Legalization: A Prospective Observational Study of 1000 Patients in Canada.
Journal: ACR open rheumatology
Published: February 14, 2020
5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trial.
Journal: The Lancet. Rheumatology
Published: January 17, 2020
Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 3-year results from the phase III trial, MEASURE 2.
Journal: RMD open
Published: September 27, 2017
Assessing process of care in rheumatoid arthritis at McGill University hospitals.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: May 15, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026